YIDU TECH's Affiliate Secures Contract for Tianjin Cancer Hospital's Intelligent Clinical Research Platform

Stock News05-21

YIDU TECH (02158) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has recently been awarded the contract for the Intelligent Clinical Research Integrated Platform Construction Project at Tianjin Cancer Hospital. The total project value is approximately RMB 7.39 million.

YIDU TECH is a core driver of intelligent transformation within China's healthcare system. The company deeply empowers the entire industry chain encompassing "healthcare, pharmaceuticals, insurance, and patients" through intelligent decision-making, aiming to make precision medicine accessible to everyone.

By simulating clinical decision-making logic, using real disease progression as training data, and undergoing continuous real-world validation, the company has developed an "AI that truly understands disease." This provides measurable value to key segments of the medical ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the distance from molecule to patient, enabling patients to access more affordable precision diagnosis and treatment, and providing public health systems with more scientific support.

YIDU TECH leverages its proprietary, system-level intelligence to create a more resilient, compassionate, inclusive, and efficient future for healthcare.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1100595676?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-21 12:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100595676","market":"sg","top_or_hot":-1,"title":"YIDU TECH's Affiliate Secures Contract for Tianjin Cancer Hospital's Intelligent Clinical Research Platform","media":"Stock News","content":"<p>YIDU TECH (02158) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has recently been awarded the contract for the Intelligent Clinical Research Integrated Platform Construction Project at Tianjin Cancer Hospital. The total project value is approximately RMB 7.39 million.</p>\n<p>YIDU TECH is a core driver of intelligent transformation within China's healthcare system. The company deeply empowers the entire industry chain encompassing \"healthcare, pharmaceuticals, insurance, and patients\" through intelligent decision-making, aiming to make precision medicine accessible to everyone.</p>\n<p>By simulating clinical decision-making logic, using real disease progression as training data, and undergoing continuous real-world validation, the company has developed an \"AI that truly understands disease.\" This provides measurable value to key segments of the medical ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the distance from molecule to patient, enabling patients to access more affordable precision diagnosis and treatment, and providing public health systems with more scientific support.</p>\n<p>YIDU TECH leverages its proprietary, system-level intelligence to create a more resilient, compassionate, inclusive, and efficient future for healthcare.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>YIDU TECH's Affiliate Secures Contract for Tianjin Cancer Hospital's Intelligent Clinical Research Platform</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYIDU TECH's Affiliate Secures Contract for Tianjin Cancer Hospital's Intelligent Clinical Research Platform\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-21 12:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>YIDU TECH (02158) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has recently been awarded the contract for the Intelligent Clinical Research Integrated Platform Construction Project at Tianjin Cancer Hospital. The total project value is approximately RMB 7.39 million.</p>\n<p>YIDU TECH is a core driver of intelligent transformation within China's healthcare system. The company deeply empowers the entire industry chain encompassing \"healthcare, pharmaceuticals, insurance, and patients\" through intelligent decision-making, aiming to make precision medicine accessible to everyone.</p>\n<p>By simulating clinical decision-making logic, using real disease progression as training data, and undergoing continuous real-world validation, the company has developed an \"AI that truly understands disease.\" This provides measurable value to key segments of the medical ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the distance from molecule to patient, enabling patients to access more affordable precision diagnosis and treatment, and providing public health systems with more scientific support.</p>\n<p>YIDU TECH leverages its proprietary, system-level intelligence to create a more resilient, compassionate, inclusive, and efficient future for healthcare.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02158","symbol_name":"医渡科技","start_time":0,"source_url":"","article_id":"1100595676","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100595676","pubTimestamp":1779338179,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"YIDU TECH (02158) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has recently been awarded the contract for the Intelligent Clinical Research Integrated Platform...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02158":"医渡科技","BK1518":"SaaS概念","BK1189":"医疗保健技术","BK1617":"AI医疗"},"translate_title":"医渡科技附属公司获得天津肿瘤医院智能临床研究平台合同","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02158":1},"content_text":"YIDU TECH (02158) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has recently been awarded the contract for the Intelligent Clinical Research Integrated Platform Construction Project at Tianjin Cancer Hospital. The total project value is approximately RMB 7.39 million.\nYIDU TECH is a core driver of intelligent transformation within China's healthcare system. The company deeply empowers the entire industry chain encompassing \"healthcare, pharmaceuticals, insurance, and patients\" through intelligent decision-making, aiming to make precision medicine accessible to everyone.\nBy simulating clinical decision-making logic, using real disease progression as training data, and undergoing continuous real-world validation, the company has developed an \"AI that truly understands disease.\" This provides measurable value to key segments of the medical ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the distance from molecule to patient, enabling patients to access more affordable precision diagnosis and treatment, and providing public health systems with more scientific support.\nYIDU TECH leverages its proprietary, system-level intelligence to create a more resilient, compassionate, inclusive, and efficient future for healthcare.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1100595676","isCrawlerRequest":true}